430 related articles for article (PubMed ID: 18984852)
1. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
Bai X; Dinghong Q; Miao D; Goltzman D; Karaplis AC
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E79-88. PubMed ID: 18984852
[TBL] [Abstract][Full Text] [Related]
2. Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- mice.
Yuan Q; Sato T; Densmore M; Saito H; Schüler C; Erben RG; Lanske B
PLoS Genet; 2012; 8(5):e1002726. PubMed ID: 22615584
[TBL] [Abstract][Full Text] [Related]
3. Soluble Klotho causes hypomineralization in Klotho-deficient mice.
Minamizaki T; Konishi Y; Sakurai K; Yoshioka H; Aubin JE; Kozai K; Yoshiko Y
J Endocrinol; 2018 Jun; 237(3):285-300. PubMed ID: 29632215
[TBL] [Abstract][Full Text] [Related]
4. Klotho expression in long bones regulates FGF23 production during renal failure.
Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B
FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
Bai X; Miao D; Li J; Goltzman D; Karaplis AC
Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules.
Ide N; Ye R; Courbebaisse M; Olauson H; Densmore MJ; Larsson TE; Hanai JI; Lanske B
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1261-F1270. PubMed ID: 29993278
[TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.
Olauson H; Lindberg K; Amin R; Jia T; Wernerson A; Andersson G; Larsson TE
J Am Soc Nephrol; 2012 Oct; 23(10):1641-51. PubMed ID: 22878961
[TBL] [Abstract][Full Text] [Related]
8. Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice.
Leibrock CB; Alesutan I; Voelkl J; Michael D; Castor T; Kohlhofer U; Quintanilla-Martinez L; Kübler L; Mannheim JG; Pichler BJ; Rosenblatt KP; Kuro-o M; Lang F
J Mol Med (Berl); 2016 Jan; 94(1):95-106. PubMed ID: 26307633
[TBL] [Abstract][Full Text] [Related]
9. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
[TBL] [Abstract][Full Text] [Related]
10. FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.
Ma Y; Kirby BJ; Fairbridge NA; Karaplis AC; Lanske B; Kovacs CS
Endocrinology; 2017 Feb; 158(2):252-263. PubMed ID: 27929669
[TBL] [Abstract][Full Text] [Related]
11. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency.
Bai XY; Miao D; Goltzman D; Karaplis AC
J Biol Chem; 2003 Mar; 278(11):9843-9. PubMed ID: 12519781
[TBL] [Abstract][Full Text] [Related]
12. Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23.
Leifheit-Nestler M; Richter B; Basaran M; Nespor J; Vogt I; Alesutan I; Voelkl J; Lang F; Heineke J; Krick S; Haffner D
Front Endocrinol (Lausanne); 2018; 9():333. PubMed ID: 29977226
[TBL] [Abstract][Full Text] [Related]
13. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
Nakatani T; Sarraj B; Ohnishi M; Densmore MJ; Taguchi T; Goetz R; Mohammadi M; Lanske B; Razzaque MS
FASEB J; 2009 Feb; 23(2):433-41. PubMed ID: 18835926
[TBL] [Abstract][Full Text] [Related]
14. Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.
Kamiya N; Yamaguchi R; Aruwajoye O; Kim AJ; Kuroyanagi G; Phipps M; Adapala NS; Feng JQ; Kim HK
J Bone Miner Res; 2017 Aug; 32(8):1716-1726. PubMed ID: 28425622
[TBL] [Abstract][Full Text] [Related]
15. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.
Ichikawa S; Sorenson AH; Austin AM; Mackenzie DS; Fritz TA; Moh A; Hui SL; Econs MJ
Endocrinology; 2009 Jun; 150(6):2543-50. PubMed ID: 19213845
[TBL] [Abstract][Full Text] [Related]
16. [Discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis].
Nabeshima Y
Clin Calcium; 2008 Jul; 18(7):923-34. PubMed ID: 18591743
[TBL] [Abstract][Full Text] [Related]
17. FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.
Xiao Z; King G; Mancarella S; Munkhsaikhan U; Cao L; Cai C; Quarles LD
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31801907
[TBL] [Abstract][Full Text] [Related]
18. Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo.
Anour R; Andrukhova O; Ritter E; Zeitz U; Erben RG
PLoS One; 2012; 7(2):e31376. PubMed ID: 22319626
[TBL] [Abstract][Full Text] [Related]
19. FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH.
Yuan Q; Sato T; Densmore M; Saito H; Schüler C; Erben RG; Lanske B
J Bone Miner Res; 2011 Sep; 26(9):2026-35. PubMed ID: 21590742
[TBL] [Abstract][Full Text] [Related]
20. Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse.
Brownstein CA; Zhang J; Stillman A; Ellis B; Troiano N; Adams DJ; Gundberg CM; Lifton RP; Carpenter TO
Endocrinology; 2010 Feb; 151(2):492-501. PubMed ID: 19952276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]